SSY Group (HK:2005) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
SSY Group Limited has entered a strategic framework agreement with HighTide Therapeutics, Inc., focusing on joint research and development in metabolic chronic diseases and anti-aging solutions. This partnership aims to leverage both companies’ strengths to create innovative products and promote them globally. The collaboration includes establishing a joint research center and building an industry ecosystem.
For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.
